Literature DB >> 34203226

Factors Associated with Medication Non-Adherence in Patients with Dyslipidemia.

Eman Alefishat1,2,3, Anan S Jarab4, Walid Al-Qerem5, Lina Abu-Zaytoun4.   

Abstract

Lack of medication adherence among patients with dyslipidemia negatively affects health-related outcomes. This study aims to evaluate medication adherence; we also aim to investigate the predictors of non-adherence among patients with dyslipidemia in Jordan. Medication adherence was evaluated in a total of 228 dyslipidemia patients. The Beliefs about Medicines Questionnaire was also used to assess patients' beliefs about medications. The majority of the current study participants (73.2%) reported non-adherence to the prescribed medications. There were significant negative associations between medication adherence and concerns of prescription drug use (B = -0.41, p-value < 0.01), duration of dyslipidemia (B = -0.22, p-value < 0.01), and the number of medications (B = -0.64, p-value < 0.01). Positive associations were found between medication adherence and the necessity of prescription drug use (B = 0.43, p-value < 0.01), taking statin and fibrate (B = 2.04, p-value < 0.01), and moderate-intensity statin (B = 2.34, p-value < 0.01). As for patients' beliefs about medications, the item "My medicine to lower my cholesterol disrupted my life" had the highest mean (3.50 ± 0.99). This study revealed a low adherence rate to medication among patients with dyslipidemia. It also demonstrates modifiable factors such as beliefs regarding perceived risk, medication harms, treatment duration, and the number of medications associated with poor adherence in patients with dyslipidemia.

Entities:  

Keywords:  adherence; dyslipidemia; statin

Year:  2021        PMID: 34203226     DOI: 10.3390/healthcare9070813

Source DB:  PubMed          Journal:  Healthcare (Basel)        ISSN: 2227-9032


  39 in total

1.  Internal construct validity of the Shirom-Melamed Burnout Questionnaire (SMBQ).

Authors:  Åsa Lundgren-Nilsson; Ingibjörg H Jonsdottir; Julie Pallant; Gunnar Ahlborg
Journal:  BMC Public Health       Date:  2012-01-03       Impact factor: 3.295

2.  Adherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, combination therapy, and fixed-dose combination therapy.

Authors:  Caron Melikian; T Jeffrey White; Ann Vanderplas; Christopher M Dezii; Eunice Chang
Journal:  Clin Ther       Date:  2002-03       Impact factor: 3.393

3.  European Society of Cardiology: Cardiovascular Disease Statistics 2019.

Authors:  Adam Timmis; Nick Townsend; Chris P Gale; Aleksandra Torbica; Maddalena Lettino; Steffen E Petersen; Elias A Mossialos; Aldo P Maggioni; Dzianis Kazakiewicz; Heidi T May; Delphine De Smedt; Marcus Flather; Liesl Zuhlke; John F Beltrame; Radu Huculeci; Luigi Tavazzi; Gerhard Hindricks; Jeroen Bax; Barbara Casadei; Stephan Achenbach; Lucy Wright; Panos Vardas
Journal:  Eur Heart J       Date:  2020-01-01       Impact factor: 29.983

4.  Predicting 1-Year Statin Adherence Among Prevalent Users: A Retrospective Cohort Study.

Authors:  Alexis A Krumme; Jessica M Franklin; Danielle L Isaman; Olga S Matlin; Angela Y Tong; Claire M Spettell; Troyen A Brennan; William H Shrank; Niteesh K Choudhry
Journal:  J Manag Care Spec Pharm       Date:  2017-04

Review 5.  Medication adherence in inflammatory bowel disease.

Authors:  Webber Chan; Andy Chen; Darren Tiao; Christian Selinger; Rupert Leong
Journal:  Intest Res       Date:  2017-10-23

Review 6.  Relationship between depression and medication adherence in cardiovascular disease: the perfect challenge for the integrated care team.

Authors:  Carly M Goldstein; Emily C Gathright; Sarah Garcia
Journal:  Patient Prefer Adherence       Date:  2017-03-15       Impact factor: 2.711

7.  Adherence to medications and associated factors: A cross-sectional study among Palestinian hypertensive patients.

Authors:  Rowa' Al-Ramahi
Journal:  J Epidemiol Glob Health       Date:  2014-06-21

Review 8.  Management of diabetic dyslipidemia: An update.

Authors:  Ishwarlal Jialal; Gurdeep Singh
Journal:  World J Diabetes       Date:  2019-05-15

9.  Discrimination and net reclassification of cardiovascular risk with lipoprotein(a): prospective 15-year outcomes in the Bruneck Study.

Authors:  Peter Willeit; Stefan Kiechl; Florian Kronenberg; Joseph L Witztum; Peter Santer; Manuel Mayr; Qingbo Xu; Agnes Mayr; Johann Willeit; Sotirios Tsimikas
Journal:  J Am Coll Cardiol       Date:  2014-09-02       Impact factor: 24.094

10.  Beliefs about medicines and non-adherence in patients with stroke, diabetes mellitus and rheumatoid arthritis: a cross-sectional study in China.

Authors:  Li Wei; Sarah Champman; Xiaomei Li; Xin Li; Sumei Li; Ruoling Chen; Nie Bo; Angel Chater; Robert Horne
Journal:  BMJ Open       Date:  2017-10-05       Impact factor: 2.692

View more
  3 in total

1.  Exploring variables associated with medication non-adherence in patients with type 2 diabetes mellitus.

Authors:  Walid Al-Qerem; Anan S Jarab; Mohammad Badinjki; Dana Hyassat; Raghda Qarqaz
Journal:  PLoS One       Date:  2021-08-23       Impact factor: 3.240

2.  Validation of an Arabic Version of the Self-Efficacy for Appropriate Medication Use Scale.

Authors:  Hawazin Alhazzani; Ghaida AlAmmari; Nouf AlRajhi; Ibrahim Sales; Amr Jamal; Turky H Almigbal; Mohammed A Batais; Yousif A Asiri; Yazed AlRuthia
Journal:  Int J Environ Res Public Health       Date:  2021-11-15       Impact factor: 3.390

3.  Validation of the Arabic version of medication adherence report scale questionnaire and beliefs about medication -specific questionnaire: A factor analysis study.

Authors:  Walid Al-Qerem; Abdel Qader Al Bawab; Osama Abusara; Nimer Alkhatib; Robert Horne
Journal:  PLoS One       Date:  2022-04-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.